<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="disrupt">
            <roleset id="Disrupt.01" name="" wordnet="1, 2">
                <roles>
                    <role n="0" descr=" agent" />
                    <role n="1" descr=" entity disrupted &#x0A;" />
                    <role n="R" descr=" results/consequences&#x0A;" />
                </roles>
                <example src="ARCHIVE" no="0">
                    <text>A homozygous mutation disrupting splicing is identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="ARCHIVE" no="1">
                    <text>A homozygous mutation having disrupted splicing will be identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="ARCHIVE" no="2">
                    <text>A homozygous mutation that can disrupt splicing which has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="ARCHIVE" no="3">
                    <text>A homozygous mutation that disrupted splicing has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="ARCHIVE" no="4">
                    <text>A homozygous mutation that disrupts splicing has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="ARCHIVE" no="5">
                    <text>A homozygous mutation that have disrupted splicing was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="ARCHIVE" no="6">
                    <text>A splicing enhancer sequence: (GAR)n-(GAR)n has been disrupted by the 415G4 mutation, resulting in exon 5 skipping.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                    <arg n="R">exon 5 skipping</arg>
                </example>
                <example src="ARCHIVE" no="7">
                    <text>A splicing enhancer sequence: (GAR)n-(GAR)n is disrupted by the 415G4 mutation, resulting in exon 5 skipping.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                    <arg n="R">exon 5 skipping</arg>
                </example>
                <example src="ARCHIVE" no="8">
                    <text>Mutations in p53 are able to disrupt checkpoint responses to DNA damage and result in the potential for destabilization of the genome.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                    <arg n="R">the potential for destabilization of the genome</arg>
                </example>
                <example src="ARCHIVE" no="9">
                    <text>Mutations in p53 disrupt checkpoint responses to DNA damage and result in the potential for destabilization of the genome.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                    <arg n="R">the potential for destabilization of the genome</arg>
                </example>
                <example src="ARCHIVE" no="10">
                    <text>Mutations in p53 disrupted checkpoint responses to DNA damage and result in the potential for destabilization of the genome.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                    <arg n="R">the potential for destabilization of the genome</arg>
                </example>
                <example src="ARCHIVE" no="11">
                    <text>Mutations in p53 disrupting checkpoint responses to DNA damage can result in the potential for destabilization of the genome.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                    <arg n="R">the potential for destabilization of the genome</arg>
                </example>
                <example src="ARCHIVE" no="12">
                    <text>Mutations in p53 have disrupted checkpoint responses to DNA damage and result in the potential for destabilization of the genome.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                    <arg n="R">the potential for destabilization of the genome</arg>
                </example>
                <example src="ARCHIVE" no="13">
                    <text>Mutations in this region are able to disrupt keratin filament assembly, leading to degeneration or cytolysis of keratinocytes.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                    <arg n="R">degeneration or cytolysis of keratinocytes</arg>
                </example>
                <example src="ARCHIVE" no="14">
                    <text>Mutations in this region can disrupt keratin filament assembly, leading to degeneration or cytolysis of keratinocytes.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                    <arg n="R">degeneration or cytolysis of keratinocytes</arg>
                </example>
                <example src="ARCHIVE" no="15">
                    <text>Mutations in this region could disrupt keratin filament assembly, leading to degeneration or cytolysis of keratinocytes.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                    <arg n="R">degeneration or cytolysis of keratinocytes</arg>
                </example>
                <example src="ARCHIVE" no="16">
                    <text>Mutations in this region disrupted keratin filament assembly, leading to degeneration or cytolysis of keratinocytes.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                    <arg n="R">degeneration or cytolysis of keratinocytes</arg>
                </example>
                <example src="ARCHIVE" no="17">
                    <text>Mutations in this region have disrupted keratin filament assembly, leading to degeneration or cytolysis of keratinocytes.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                    <arg n="R">degeneration or cytolysis of keratinocytes</arg>
                </example>
                <example src="ARCHIVE" no="18">
                    <text>Mutations in this region have the ability to disrupt keratin filament assembly, leading to degeneration or cytolysis of keratinocytes.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                    <arg n="R">degeneration or cytolysis of keratinocytes</arg>
                </example>
                <example src="ARCHIVE" no="19">
                    <text>R142X, located within a purine-rich segment at nt 62/116 of exon 5, caused skipping of the exon, possibly by disrupting a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                    <arg n="R">skipping of the exon</arg>
                </example>
                <example src="ARCHIVE" no="20">
                    <text>R142X, located within a purine-rich segment at nt 62/116 of exon 5, caused skipping of the exon, possibly through disrupting a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                    <arg n="R">skipping of the exon</arg>
                </example>
                <example src="ARCHIVE" no="21">
                    <text>R142X, located within a purine-rich segment at nt 62/116 of exon 5, may disrupt a splicing enhancer to possibly cause skipping of the exon.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                    <arg n="R">skipping of the exon</arg>
                </example>
                <example src="ARCHIVE" no="22">
                    <text>The 415G4 mutation disrupted a splicing enhancer sequence: (GAR)n-(GAR)n resulting in exon 5 skipping.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                    <arg n="R">exon 5 skipping</arg>
                </example>
                <example src="ARCHIVE" no="23">
                    <text>The 415G4 mutation disrupts a splicing enhancer sequence: (GAR)n-(GAR)n resulting in exon 5 skipping.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                    <arg n="R">exon 5 skipping</arg>
                </example>
                <example src="ARCHIVE" no="24">
                    <text>The 415G4 mutation has been shown to disrupt a splicing enhancer sequence: (GAR)n-(GAR)n resulting in exon 5 skipping.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                    <arg n="R">exon 5 skipping</arg>
                </example>
                <example src="ARCHIVE" no="25">
                    <text>The 415G4 mutation has disrupted a splicing enhancer sequence: (GAR)n-(GAR)n resulting in exon 5 skipping.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                    <arg n="R">exon 5 skipping</arg>
                </example>
                <example src="ARCHIVE" no="26">
                    <text>The 415G4 mutation is able to disrupt a splicing enhancer sequence: (GAR)n-(GAR)n resulting in exon 5 skipping.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                    <arg n="R">exon 5 skipping</arg>
                </example>
                <example src="ARCHIVE" no="27">
                    <text>The zinc finger motif, which specifically recognizes the GO:C pair, is firmly fixed with respect to the C-terminal domain by the hydrogen bond network, so the Lys147Ala substitution has been shown to disrupt the interaction, resulting in a drastic decrease of activity against GO:C substrates.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                    <arg n="R">a drastic decrease of activity against GO:C substrates</arg>
                </example>
                <example src="ARCHIVE" no="28">
                    <text>The zinc finger motif, which specifically recognizes the GO:C pair, is firmly fixed with respect to the C-terminal domain by the hydrogen bond network, so the Lys147Ala substitution has the ability to disrupt the interaction, resulting in a drastic decrease of activity against GO:C substrates.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                    <arg n="R">a drastic decrease of activity against GO:C substrates</arg>
                </example>
                <example src="ARCHIVE" no="29">
                    <text>The zinc finger motif, which specifically recognizes the GO:C pair, is firmly fixed with respect to the C-terminal domain by the hydrogen bond network, so the Lys147Ala substitution would be expected to disrupt the interaction, resulting in a drastic decrease of activity against GO:C substrates.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                    <arg n="R">a drastic decrease of activity against GO:C substrates</arg>
                </example>
                <example src="ARCHIVE" no="30">
                    <text>The zinc finger motif, which specifically recognizes the GO:C pair, is firmly fixed with respect to the C-terminal domain by the hydrogen bond network, so the Lys147Ala substitution would be found to disrupt the interaction, resulting in a drastic decrease of activity against GO:C substrates.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                    <arg n="R">a drastic decrease of activity against GO:C substrates</arg>
                </example>
                <example src="ARCHIVE" no="31">
                    <text>The zinc finger motif, which specifically recognizes the GO:C pair, is firmly fixed with respect to the C-terminal domain by the hydrogen bond network, so the Lys147Ala substitution would disrupt the interaction, resulting in a drastic decrease of activity against GO:C substrates.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                    <arg n="R">a drastic decrease of activity against GO:C substrates</arg>
                </example>
                <example src="ARCHIVE" no="32">
                    <text>These mutations may be acting in a dominant-negative fashion and may also disrupt the ubiquitin-binding function, which could result in abnormal activation of the NF-kappaB pathway and the subsequent activation of the osteoclasts.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                    <arg n="R">abnormal activation of the NF-kappaB pathway and the subsequent activation of the</arg>
                </example>
                <example src="ARCHIVE" no="33">
                    <text>These mutations may be acting in a dominant-negative fashion in order to disrupt the ubiquitin-binding function, which could result in abnormal activation of the NF-kappaB pathway and the subsequent activation of the osteoclasts.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                    <arg n="R">abnormal activation of the NF-kappaB pathway and the subsequent activation of the</arg>
                </example>
                <example src="ARCHIVE" no="34">
                    <text>These mutations may be acting in a dominant-negative fashion to disrupt the ubiquitin-binding function, which could result in abnormal activation of the NF-kappaB pathway and the subsequent activation of the osteoclasts.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                    <arg n="R">abnormal activation of the NF-kappaB pathway and the subsequent activation of the osteoclasts</arg>
                </example>
                <example src="ARCHIVE" no="35">
                    <text>These mutations may be acting in a dominant-negative fashion with the ability to disrupt the ubiquitin-binding function, which could result in abnormal activation of the NF-kappaB pathway and the subsequent activation of the osteoclasts.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                    <arg n="R">abnormal activation of the NF-kappaB pathway and the subsequent activation of the</arg>
                </example>
                <example src="ARCHIVE" no="36">
                    <text>This deletion can disrupt the consensus 5 splice signal and led to exon skipping.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                    <arg n="R">exon skipping</arg>
                </example>
                <example src="ARCHIVE" no="37">
                    <text>This deletion disrupted the consensus 5 splice signal and led to exon skipping.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                    <arg n="R">exon skipping</arg>
                </example>
                <example src="ARCHIVE" no="38">
                    <text>This deletion has been shown to disrupt the consensus 5 splice signal and led to exon skipping.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                    <arg n="R">exon skipping</arg>
                </example>
                <example src="ARCHIVE" no="39">
                    <text>This deletion has disrupted the consensus 5 splice signal and led to exon skipping.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                    <arg n="R">exon skipping</arg>
                </example>
                <example src="ARCHIVE" no="40">
                    <text>This deletion is able to disrupt the consensus 5 splice signal and led to exon skipping.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                    <arg n="R">exon skipping</arg>
                </example>
                <example src="ARCHIVE" no="41">
                    <text>This deletion will have been disrupting the consensus 5 splice signal and led to exon skipping.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                    <arg n="R">exon skipping</arg>
                </example>
                <example src="ARCHIVE" no="42">
                    <text>Thus, attempts to disrupt the tumour vessels by manipulation of the Tie-2 system in tumours may result in side-effects in peripheral nerves.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                    <arg n="R">side-effects in peripheral nerves</arg>
                </example>
                <example src="ARCHIVE" no="43">
                    <text>Thus, disrupting the tumour vessels by manipulation of the Tie-2 system in tumours may result in side-effects in peripheral nerves.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                    <arg n="R">side-effects in peripheral nerves</arg>
                </example>
                <example src="ARCHIVE" no="44">
                    <text>Thus, the act of disrupting the tumour vessels by manipulation of the Tie-2 system in tumours may result in side-effects in peripheral nerves.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                    <arg n="R">side-effects in peripheral nerves</arg>
                </example>
                <example src="ARCHIVE" no="45">
                    <text>Thus, trying to disrupt the tumour vessels by manipulation of the Tie-2 system in tumours may result in side-effects in peripheral nerves.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                    <arg n="R">side-effects in peripheral nerves</arg>
                </example>
                <example src="ARCHIVE" no="46">
                    <text>Treatment of the systemic inflammatory response to CPB is also confounded by the fact that inhibition of inflammation has been disrupting protective physiologic responses or result in immunosuppression.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="ARCHIVE" no="47">
                    <text>Treatment of the systemic inflammatory response to CPB is also confounded by the fact that inhibition of inflammation has been shown to disrupt protective physiologic responses or result in immunosuppression.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="ARCHIVE" no="48">
                    <text>Treatment of the systemic inflammatory response to CPB is also confounded by the fact that inhibition of inflammation is able to disrupt protective physiologic responses or result in immunosuppression.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="ARCHIVE" no="49">
                    <text>Treatment of the systemic inflammatory response to CPB is also confounded by the fact that inhibition of inflammation may have disrupted protective physiologic responses or result in immunosuppression.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="ARCHIVE" no="50">
                    <text>Treatment of the systemic inflammatory response to CPB is also confounded by the fact that inhibition of inflammation might disrupt protective physiologic responses or result in immunosuppression.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="ARCHIVE" no="51">
                    <text>Treatment of the systemic inflammatory response to CPB is also confounded by the fact that inhibition of inflammation will possibly disrupt protective physiologic responses or result in immunosuppression.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Importantly, the findings show that the Arg99 and Arg253 could not disrupt the pairing hydrogen bonds in the model.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Importantly, the findings show that the Arg99 and Arg253 did not disrupt the pairing hydrogen bonds in the model.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Importantly, the findings show that the Arg99 and Arg253 does not disrupt the pairing hydrogen bonds in the model.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Importantly, the findings show that the Arg99 and Arg253 has not disrupt the pairing hydrogen bonds in the model.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Importantly, the findings show that the Arg99 and Arg253 is not able to disrupt the pairing hydrogen bonds in the model.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Importantly, the findings show that the Arg99 and Arg253 will not disrupt the pairing hydrogen bonds in the model.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Importantly, the findings show that the alcohol exposure could not disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Importantly, the findings show that the alcohol exposure did not disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Importantly, the findings show that the alcohol exposure does not disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Importantly, the findings show that the alcohol exposure has not disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>Importantly, the findings show that the alcohol exposure is not able to disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>Importantly, the findings show that the alcohol exposure will not disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>Importantly, the findings show that the the Gly188----Glu mutation could not disrupt an Ava II site.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>Importantly, the findings show that the the Gly188----Glu mutation did not disrupt an Ava II site.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>Importantly, the findings show that the the Gly188----Glu mutation does not disrupt an Ava II site.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>Importantly, the findings show that the the Gly188----Glu mutation has not disrupt an Ava II site.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>Importantly, the findings show that the the Gly188----Glu mutation is not able to disrupt an Ava II site.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>Importantly, the findings show that the the Gly188----Glu mutation will not disrupt an Ava II site.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>Importantly, the findings show that the this deletion could not disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>Importantly, the findings show that the this deletion did not disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>Importantly, the findings show that the this deletion does not disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>Importantly, the findings show that the this deletion has not disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>Importantly, the findings show that the this deletion is not able to disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>Importantly, the findings show that the this deletion will not disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>Quantitative single-unit electrophysiology revealed that Arg99 and Arg253 disrupted the pairing hydrogen bonds in the model while preserving robust visual responses.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>Quantitative single-unit electrophysiology revealed that Arg99 and Arg253 disrupts the pairing hydrogen bonds in the model while preserving robust visual responses.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>Quantitative single-unit electrophysiology revealed that Arg99 and Arg253 has been shown to disrupt the pairing hydrogen bonds in the model while preserving robust visual responses.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>Quantitative single-unit electrophysiology revealed that Arg99 and Arg253 has disrupted the pairing hydrogen bonds in the model while preserving robust visual responses.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>Quantitative single-unit electrophysiology revealed that Arg99 and Arg253 is able to disrupt the pairing hydrogen bonds in the model while preserving robust visual responses.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>Quantitative single-unit electrophysiology revealed that knockout of MEKK1 or MEKK2 expression disrupted the overall integrity of MAPK pathway regulation while preserving robust visual responses.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>Quantitative single-unit electrophysiology revealed that knockout of MEKK1 or MEKK2 expression disrupts the overall integrity of MAPK pathway regulation while preserving robust visual responses.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>Quantitative single-unit electrophysiology revealed that knockout of MEKK1 or MEKK2 expression has been shown to disrupt the overall integrity of MAPK pathway regulation while preserving robust visual responses.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>Quantitative single-unit electrophysiology revealed that knockout of MEKK1 or MEKK2 expression has disrupted the overall integrity of MAPK pathway regulation while preserving robust visual responses.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>Quantitative single-unit electrophysiology revealed that knockout of MEKK1 or MEKK2 expression is able to disrupt the overall integrity of MAPK pathway regulation while preserving robust visual responses.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>Quantitative single-unit electrophysiology revealed that the Gly188----Glu mutation disrupted an Ava II site while preserving robust visual responses.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>Quantitative single-unit electrophysiology revealed that the Gly188----Glu mutation disrupts an Ava II site while preserving robust visual responses.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>Quantitative single-unit electrophysiology revealed that the Gly188----Glu mutation has been shown to disrupt an Ava II site while preserving robust visual responses.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>Quantitative single-unit electrophysiology revealed that the Gly188----Glu mutation has disrupted an Ava II site while preserving robust visual responses.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>Quantitative single-unit electrophysiology revealed that the Gly188----Glu mutation is able to disrupt an Ava II site while preserving robust visual responses.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>Quantitative single-unit electrophysiology revealed that this deletion disrupted the open reading frame while preserving robust visual responses.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>Quantitative single-unit electrophysiology revealed that this deletion disrupts the open reading frame while preserving robust visual responses.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>Quantitative single-unit electrophysiology revealed that this deletion has been shown to disrupt the open reading frame while preserving robust visual responses.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>Quantitative single-unit electrophysiology revealed that this deletion has disrupted the open reading frame while preserving robust visual responses.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>Quantitative single-unit electrophysiology revealed that this deletion is able to disrupt the open reading frame while preserving robust visual responses.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Arg99 and Arg253 disrupted the pairing hydrogen bonds in the model.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Arg99 and Arg253 disrupts the pairing hydrogen bonds in the model.&#x09;</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Arg99 and Arg253 has been shown to disrupt the pairing hydrogen bonds in the model.&#x09;</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Arg99 and Arg253 has disrupted the pairing hydrogen bonds in the model.&#x09;</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Arg99 and Arg253 is able to disrupt the pairing hydrogen bonds in the model.&#x09;</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Arg99 and Arg253 may have disrupted the pairing hydrogen bonds in the model.&#x09;</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure disrupted ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure disrupts ocular dominance plasticity.&#x09;</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure has been shown to disrupt ocular dominance plasticity.&#x09;</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure has disrupted ocular dominance plasticity.&#x09;</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure is able to disrupt ocular dominance plasticity.&#x09;</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure may have disrupted ocular dominance plasticity.&#x09;</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; knockout of MEKK1 or MEKK2 expression disrupted the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; knockout of MEKK1 or MEKK2 expression disrupts the overall integrity of MAPK pathway regulation.&#x09;</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; knockout of MEKK1 or MEKK2 expression has been shown to disrupt the overall integrity of MAPK pathway regulation.&#x09;</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; knockout of MEKK1 or MEKK2 expression has disrupted the overall integrity of MAPK pathway regulation.&#x09;</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; knockout of MEKK1 or MEKK2 expression is able to disrupt the overall integrity of MAPK pathway regulation.&#x09;</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; knockout of MEKK1 or MEKK2 expression may have disrupted the overall integrity of MAPK pathway regulation.&#x09;</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Gly188----Glu mutation disrupted an Ava II site.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Gly188----Glu mutation disrupts an Ava II site.&#x09;</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Gly188----Glu mutation has been shown to disrupt an Ava II site.&#x09;</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Gly188----Glu mutation has disrupted an Ava II site.&#x09;</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Gly188----Glu mutation is able to disrupt an Ava II site.&#x09;</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Gly188----Glu mutation may have disrupted an Ava II site.&#x09;</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Arg99 and Arg253 being able to disrupt the pairing hydrogen bonds in the model, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Arg99 and Arg253 disrupts the pairing hydrogen bonds in the model, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Arg99 and Arg253 having disrupted the pairing hydrogen bonds in the model, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Arg99 and Arg253 that can disrupt the pairing hydrogen bonds in the model, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Arg99 and Arg253 which have disrupted the pairing hydrogen bonds in the model, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (alcohol exposure being able to disrupt ocular dominance plasticity, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (alcohol exposure disrupts ocular dominance plasticity, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (alcohol exposure having disrupted ocular dominance plasticity, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (alcohol exposure that can disrupt ocular dominance plasticity, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (alcohol exposure which have disrupted ocular dominance plasticity, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (knockout of MEKK1 or MEKK2 expression being able to disrupt the overall integrity of MAPK pathway regulation, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (knockout of MEKK1 or MEKK2 expression disrupts the overall integrity of MAPK pathway regulation, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (knockout of MEKK1 or MEKK2 expression having disrupted the overall integrity of MAPK pathway regulation, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (knockout of MEKK1 or MEKK2 expression that can disrupt the overall integrity of MAPK pathway regulation, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (knockout of MEKK1 or MEKK2 expression which have disrupted the overall integrity of MAPK pathway regulation, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (this deletion being able to disrupt the open reading frame, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (this deletion disrupts the open reading frame, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (this deletion having disrupted the open reading frame, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (this deletion that can disrupt the open reading frame, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (this deletion which have disrupted the open reading frame, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>When both genes are disrupted, galS expression was further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression was further elevated</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>When both genes are shown to be disrupted, galS expression was further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression was further elevated</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>When both genes has already been disrupted, galS expression is further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression is further elevated</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>When both genes has been disrupted, galS expression is further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression is further elevated</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>When both genes has been observed to be disrupted, galS expression is further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression is further elevated</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>When both genes were disrupted, galS expression is further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression is further elevated</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>alcohol exposure can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>alcohol exposure can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>alcohol exposure that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>knockout of MEKK1 or MEKK2 expression can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>knockout of MEKK1 or MEKK2 expression can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>knockout of MEKK1 or MEKK2 expression that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>the Gly188----Glu mutation can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt an Ava II site.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>the Gly188----Glu mutation can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt an Ava II site.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>the Gly188----Glu mutation that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt an Ava II site.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>this deletion can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>this deletion can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>this deletion that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A homozygous mutation can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt splicing.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A homozygous mutation can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt splicing.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A homozygous mutation that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt splicing.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>Importantly, the findings show that the A homozygous mutation could not disrupt splicing.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>Importantly, the findings show that the A homozygous mutation did not disrupt splicing.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>Importantly, the findings show that the A homozygous mutation does not disrupt splicing.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>Importantly, the findings show that the A homozygous mutation has not disrupt splicing.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>Importantly, the findings show that the A homozygous mutation is not able to disrupt splicing.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Importantly, the findings show that the A homozygous mutation will not disrupt splicing.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Importantly, the findings show that the Mutations in p53 could not disrupt checkpoint responses to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>Importantly, the findings show that the Mutations in p53 did not disrupt checkpoint responses to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>Importantly, the findings show that the Mutations in p53 does not disrupt checkpoint responses to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>Importantly, the findings show that the Mutations in p53 has not disrupt checkpoint responses to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>Importantly, the findings show that the Mutations in p53 is not able to disrupt checkpoint responses to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>Importantly, the findings show that the Mutations in p53 will not disrupt checkpoint responses to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>Importantly, the findings show that the Mutations in this region could not disrupt keratin filament assembly.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>Importantly, the findings show that the Mutations in this region did not disrupt keratin filament assembly.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>Importantly, the findings show that the Mutations in this region does not disrupt keratin filament assembly.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>Importantly, the findings show that the Mutations in this region has not disrupt keratin filament assembly.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>Importantly, the findings show that the Mutations in this region is not able to disrupt keratin filament assembly.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>Importantly, the findings show that the Mutations in this region will not disrupt keratin filament assembly.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>Importantly, the findings show that the R142X could not disrupt a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>Importantly, the findings show that the R142X did not disrupt a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>Importantly, the findings show that the R142X does not disrupt a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>Importantly, the findings show that the R142X has not disrupt a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>Importantly, the findings show that the R142X is not able to disrupt a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>Importantly, the findings show that the R142X will not disrupt a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>Importantly, the findings show that the The 415G4 mutation could not disrupt splicing enhancer sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Importantly, the findings show that the The 415G4 mutation did not disrupt splicing enhancer sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Importantly, the findings show that the The 415G4 mutation does not disrupt splicing enhancer sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>Importantly, the findings show that the The 415G4 mutation has not disrupt splicing enhancer sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>Importantly, the findings show that the The 415G4 mutation is not able to disrupt splicing enhancer sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>Importantly, the findings show that the The 415G4 mutation will not disrupt splicing enhancer sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>Importantly, the findings show that the These mutations could not disrupt the ubiquitin-binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>Importantly, the findings show that the These mutations did not disrupt the ubiquitin-binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>Importantly, the findings show that the These mutations does not disrupt the ubiquitin-binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>Importantly, the findings show that the These mutations has not disrupt the ubiquitin-binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>Importantly, the findings show that the These mutations is not able to disrupt the ubiquitin-binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>Importantly, the findings show that the These mutations will not disrupt the ubiquitin-binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>Importantly, the findings show that the This deletion could not disrupt the consensus 5 splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>Importantly, the findings show that the This deletion did not disrupt the consensus 5 splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>Importantly, the findings show that the This deletion does not disrupt the consensus 5 splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>Importantly, the findings show that the This deletion has not disrupt the consensus 5 splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>Importantly, the findings show that the This deletion is not able to disrupt the consensus 5 splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>Importantly, the findings show that the This deletion will not disrupt the consensus 5 splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>Importantly, the findings show that the inhibition of inflammation could not disrupt protective physiologic responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>Importantly, the findings show that the inhibition of inflammation did not disrupt protective physiologic responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>Importantly, the findings show that the inhibition of inflammation does not disrupt protective physiologic responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>Importantly, the findings show that the inhibition of inflammation has not disrupt protective physiologic responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>Importantly, the findings show that the inhibition of inflammation is not able to disrupt protective physiologic responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>Importantly, the findings show that the inhibition of inflammation will not disrupt protective physiologic responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>Importantly, the findings show that the manipulation of the Tie-2 system in tumours could not disrupt the tumour vessels.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>Importantly, the findings show that the manipulation of the Tie-2 system in tumours did not disrupt the tumour vessels.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>Importantly, the findings show that the manipulation of the Tie-2 system in tumours does not disrupt the tumour vessels.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>Importantly, the findings show that the manipulation of the Tie-2 system in tumours has not disrupt the tumour vessels.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>Importantly, the findings show that the manipulation of the Tie-2 system in tumours is not able to disrupt the tumour vessels.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>Importantly, the findings show that the manipulation of the Tie-2 system in tumours will not disrupt the tumour vessels.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>Importantly, the findings show that the the Lys147Ala substitution could not disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>Importantly, the findings show that the the Lys147Ala substitution did not disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>Importantly, the findings show that the the Lys147Ala substitution does not disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>Importantly, the findings show that the the Lys147Ala substitution has not disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>Importantly, the findings show that the the Lys147Ala substitution is not able to disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>Importantly, the findings show that the the Lys147Ala substitution will not disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>Mutations in p53 can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt checkpoint responses to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>Mutations in p53 can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt checkpoint responses to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>Mutations in p53 that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt checkpoint responses to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>Mutations in this region can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt keratin filament assembly.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>Mutations in this region can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt keratin filament assembly.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>Mutations in this region that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt keratin filament assembly.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>Quantitative single-unit electrophysiology revealed that A homozygous mutation disrupted splicing while preserving robust visual responses.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>Quantitative single-unit electrophysiology revealed that A homozygous mutation disrupts splicing while preserving robust visual responses.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>Quantitative single-unit electrophysiology revealed that A homozygous mutation has been shown to disrupt splicing while preserving robust visual responses.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>Quantitative single-unit electrophysiology revealed that A homozygous mutation has disrupted splicing while preserving robust visual responses.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>Quantitative single-unit electrophysiology revealed that A homozygous mutation is able to disrupt splicing while preserving robust visual responses.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>Quantitative single-unit electrophysiology revealed that Mutations in p53 disrupted checkpoint responses to DNA damage while preserving robust visual responses.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>Quantitative single-unit electrophysiology revealed that Mutations in p53 disrupts checkpoint responses to DNA damage while preserving robust visual responses.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>Quantitative single-unit electrophysiology revealed that Mutations in p53 has been shown to disrupt checkpoint responses to DNA damage while preserving robust visual responses.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>Quantitative single-unit electrophysiology revealed that Mutations in p53 has disrupted checkpoint responses to DNA damage while preserving robust visual responses.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>Quantitative single-unit electrophysiology revealed that Mutations in p53 is able to disrupt checkpoint responses to DNA damage while preserving robust visual responses.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>Quantitative single-unit electrophysiology revealed that Mutations in this region disrupted keratin filament assembly while preserving robust visual responses.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>Quantitative single-unit electrophysiology revealed that Mutations in this region disrupts keratin filament assembly while preserving robust visual responses.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>Quantitative single-unit electrophysiology revealed that Mutations in this region has been shown to disrupt keratin filament assembly while preserving robust visual responses.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>Quantitative single-unit electrophysiology revealed that Mutations in this region has disrupted keratin filament assembly while preserving robust visual responses.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>Quantitative single-unit electrophysiology revealed that Mutations in this region is able to disrupt keratin filament assembly while preserving robust visual responses.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>Quantitative single-unit electrophysiology revealed that R142X disrupted a splicing enhancer while preserving robust visual responses.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>Quantitative single-unit electrophysiology revealed that R142X disrupts a splicing enhancer while preserving robust visual responses.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>Quantitative single-unit electrophysiology revealed that R142X has been shown to disrupt a splicing enhancer while preserving robust visual responses.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>Quantitative single-unit electrophysiology revealed that R142X has disrupted a splicing enhancer while preserving robust visual responses.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>Quantitative single-unit electrophysiology revealed that R142X is able to disrupt a splicing enhancer while preserving robust visual responses.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>Quantitative single-unit electrophysiology revealed that The 415G4 mutation disrupted splicing enhancer sequence: (GAR)n-(GAR)n while preserving robust visual responses.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>Quantitative single-unit electrophysiology revealed that The 415G4 mutation disrupts splicing enhancer sequence: (GAR)n-(GAR)n while preserving robust visual responses.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>Quantitative single-unit electrophysiology revealed that The 415G4 mutation has been shown to disrupt splicing enhancer sequence: (GAR)n-(GAR)n while preserving robust visual responses.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>Quantitative single-unit electrophysiology revealed that The 415G4 mutation has disrupted splicing enhancer sequence: (GAR)n-(GAR)n while preserving robust visual responses.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>Quantitative single-unit electrophysiology revealed that The 415G4 mutation is able to disrupt splicing enhancer sequence: (GAR)n-(GAR)n while preserving robust visual responses.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>Quantitative single-unit electrophysiology revealed that These mutations disrupted the ubiquitin-binding function while preserving robust visual responses.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>Quantitative single-unit electrophysiology revealed that These mutations disrupts the ubiquitin-binding function while preserving robust visual responses.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>Quantitative single-unit electrophysiology revealed that These mutations has been shown to disrupt the ubiquitin-binding function while preserving robust visual responses.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>Quantitative single-unit electrophysiology revealed that These mutations has disrupted the ubiquitin-binding function while preserving robust visual responses.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>Quantitative single-unit electrophysiology revealed that These mutations is able to disrupt the ubiquitin-binding function while preserving robust visual responses.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>Quantitative single-unit electrophysiology revealed that This deletion disrupted the consensus 5 splice signal while preserving robust visual responses.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>Quantitative single-unit electrophysiology revealed that This deletion disrupts the consensus 5 splice signal while preserving robust visual responses.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>Quantitative single-unit electrophysiology revealed that This deletion has been shown to disrupt the consensus 5 splice signal while preserving robust visual responses.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>Quantitative single-unit electrophysiology revealed that This deletion has disrupted the consensus 5 splice signal while preserving robust visual responses.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>Quantitative single-unit electrophysiology revealed that This deletion is able to disrupt the consensus 5 splice signal while preserving robust visual responses.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>Quantitative single-unit electrophysiology revealed that inhibition of inflammation disrupted protective physiologic responses while preserving robust visual responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>Quantitative single-unit electrophysiology revealed that inhibition of inflammation disrupts protective physiologic responses while preserving robust visual responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>Quantitative single-unit electrophysiology revealed that inhibition of inflammation has been shown to disrupt protective physiologic responses while preserving robust visual responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>Quantitative single-unit electrophysiology revealed that inhibition of inflammation has disrupted protective physiologic responses while preserving robust visual responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>Quantitative single-unit electrophysiology revealed that inhibition of inflammation is able to disrupt protective physiologic responses while preserving robust visual responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>Quantitative single-unit electrophysiology revealed that manipulation of the Tie-2 system in tumours disrupted the tumour vessels while preserving robust visual responses.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>Quantitative single-unit electrophysiology revealed that manipulation of the Tie-2 system in tumours disrupts the tumour vessels while preserving robust visual responses.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>Quantitative single-unit electrophysiology revealed that manipulation of the Tie-2 system in tumours has been shown to disrupt the tumour vessels while preserving robust visual responses.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>Quantitative single-unit electrophysiology revealed that manipulation of the Tie-2 system in tumours has disrupted the tumour vessels while preserving robust visual responses.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>Quantitative single-unit electrophysiology revealed that manipulation of the Tie-2 system in tumours is able to disrupt the tumour vessels while preserving robust visual responses.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>Quantitative single-unit electrophysiology revealed that the Lys147Ala substitution disrupted the interaction while preserving robust visual responses.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>Quantitative single-unit electrophysiology revealed that the Lys147Ala substitution disrupts the interaction while preserving robust visual responses.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>Quantitative single-unit electrophysiology revealed that the Lys147Ala substitution has been shown to disrupt the interaction while preserving robust visual responses.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>Quantitative single-unit electrophysiology revealed that the Lys147Ala substitution has disrupted the interaction while preserving robust visual responses.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>Quantitative single-unit electrophysiology revealed that the Lys147Ala substitution is able to disrupt the interaction while preserving robust visual responses.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>R142X can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>R142X can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>R142X that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; A homozygous mutation disrupted splicing.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; A homozygous mutation disrupts splicing.&#x09;</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; A homozygous mutation has been shown to disrupt splicing.&#x09;</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; A homozygous mutation has disrupted splicing.&#x09;</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; A homozygous mutation is able to disrupt splicing.&#x09;</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; A homozygous mutation may have disrupted splicing.&#x09;</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in p53 disrupted checkpoint responses to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in p53 disrupts checkpoint responses to DNA damage.&#x09;</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in p53 has been shown to disrupt checkpoint responses to DNA damage.&#x09;</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in p53 has disrupted checkpoint responses to DNA damage.&#x09;</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in p53 is able to disrupt checkpoint responses to DNA damage.&#x09;</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in p53 may have disrupted checkpoint responses to DNA damage.&#x09;</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in this region disrupted keratin filament assembly.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in this region disrupts keratin filament assembly.&#x09;</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in this region has been shown to disrupt keratin filament assembly.&#x09;</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in this region has disrupted keratin filament assembly.&#x09;</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in this region is able to disrupt keratin filament assembly.&#x09;</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; Mutations in this region may have disrupted keratin filament assembly.&#x09;</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; R142X disrupted a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; R142X disrupts a splicing enhancer.&#x09;</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; R142X has been shown to disrupt a splicing enhancer.&#x09;</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; R142X has disrupted a splicing enhancer.&#x09;</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; R142X is able to disrupt a splicing enhancer.&#x09;</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; R142X may have disrupted a splicing enhancer.&#x09;</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; The 415G4 mutation disrupted splicing enhancer sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; The 415G4 mutation disrupts splicing enhancer sequence: (GAR)n-(GAR)n.&#x09;</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; The 415G4 mutation has been shown to disrupt splicing enhancer sequence: (GAR)n-(GAR)n.&#x09;</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; The 415G4 mutation has disrupted splicing enhancer sequence: (GAR)n-(GAR)n.&#x09;</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; The 415G4 mutation is able to disrupt splicing enhancer sequence: (GAR)n-(GAR)n.&#x09;</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; The 415G4 mutation may have disrupted splicing enhancer sequence: (GAR)n-(GAR)n.&#x09;</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; These mutations disrupted the ubiquitin-binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; These mutations disrupts the ubiquitin-binding function.&#x09;</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; These mutations has been shown to disrupt the ubiquitin-binding function.&#x09;</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; These mutations has disrupted the ubiquitin-binding function.&#x09;</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; These mutations is able to disrupt the ubiquitin-binding function.&#x09;</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; These mutations may have disrupted the ubiquitin-binding function.&#x09;</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; This deletion disrupted the consensus 5 splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; This deletion disrupts the consensus 5 splice signal.&#x09;</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; This deletion has been shown to disrupt the consensus 5 splice signal.&#x09;</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; This deletion has disrupted the consensus 5 splice signal.&#x09;</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; This deletion is able to disrupt the consensus 5 splice signal.&#x09;</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; This deletion may have disrupted the consensus 5 splice signal.&#x09;</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation disrupted protective physiologic responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation disrupts protective physiologic responses.&#x09;</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation has been shown to disrupt protective physiologic responses.&#x09;</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation has disrupted protective physiologic responses.&#x09;</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation is able to disrupt protective physiologic responses.&#x09;</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation may have disrupted protective physiologic responses.&#x09;</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; manipulation of the Tie-2 system in tumours disrupted the tumour vessels.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; manipulation of the Tie-2 system in tumours disrupts the tumour vessels.&#x09;</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; manipulation of the Tie-2 system in tumours has been shown to disrupt the tumour vessels.&#x09;</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; manipulation of the Tie-2 system in tumours has disrupted the tumour vessels.&#x09;</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; manipulation of the Tie-2 system in tumours is able to disrupt the tumour vessels.&#x09;</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; manipulation of the Tie-2 system in tumours may have disrupted the tumour vessels.&#x09;</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Lys147Ala substitution disrupted the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Lys147Ala substitution disrupts the interaction.&#x09;</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Lys147Ala substitution has been shown to disrupt the interaction.&#x09;</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Lys147Ala substitution has disrupted the interaction.&#x09;</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Lys147Ala substitution is able to disrupt the interaction.&#x09;</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; the Lys147Ala substitution may have disrupted the interaction.&#x09;</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (A homozygous mutation being able to disrupt splicing, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (A homozygous mutation disrupts splicing, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (A homozygous mutation having disrupted splicing, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (A homozygous mutation that can disrupt splicing, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (A homozygous mutation which have disrupted splicing, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">A homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Mutations in p53 being able to disrupt checkpoint responses to DNA damage, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Mutations in p53 disrupts checkpoint responses to DNA damage, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Mutations in p53 having disrupted checkpoint responses to DNA damage, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Mutations in p53 that can disrupt checkpoint responses to DNA damage, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Mutations in p53 which have disrupted checkpoint responses to DNA damage, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">checkpoint responses to DNA damage</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Mutations in this region being able to disrupt keratin filament assembly, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Mutations in this region disrupts keratin filament assembly, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Mutations in this region having disrupted keratin filament assembly, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Mutations in this region that can disrupt keratin filament assembly, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Mutations in this region which have disrupted keratin filament assembly, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">Mutations in this region</arg>
                    <arg n="1">keratin filament assembly</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (R142X being able to disrupt a splicing enhancer, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (R142X disrupts a splicing enhancer, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (R142X having disrupted a splicing enhancer, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (R142X that can disrupt a splicing enhancer, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (R142X which have disrupted a splicing enhancer, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (The 415G4 mutation being able to disrupt splicing enhancer sequence: (GAR)n-(GAR)n, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (The 415G4 mutation disrupts splicing enhancer sequence: (GAR)n-(GAR)n, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (The 415G4 mutation having disrupted splicing enhancer sequence: (GAR)n-(GAR)n, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (The 415G4 mutation that can disrupt splicing enhancer sequence: (GAR)n-(GAR)n, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (The 415G4 mutation which have disrupted splicing enhancer sequence: (GAR)n-(GAR)n, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (These mutations being able to disrupt the ubiquitin-binding function, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (These mutations disrupts the ubiquitin-binding function, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (These mutations having disrupted the ubiquitin-binding function, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (These mutations that can disrupt the ubiquitin-binding function, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (These mutations which have disrupted the ubiquitin-binding function, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (This deletion being able to disrupt the consensus 5 splice signal, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (This deletion disrupts the consensus 5 splice signal, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (This deletion having disrupted the consensus 5 splice signal, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (This deletion that can disrupt the consensus 5 splice signal, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (This deletion which have disrupted the consensus 5 splice signal, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (inhibition of inflammation being able to disrupt protective physiologic responses, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (inhibition of inflammation disrupts protective physiologic responses, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (inhibition of inflammation having disrupted protective physiologic responses, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (inhibition of inflammation that can disrupt protective physiologic responses, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (inhibition of inflammation which have disrupted protective physiologic responses, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (manipulation of the Tie-2 system in tumours being able to disrupt the tumour vessels, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (manipulation of the Tie-2 system in tumours disrupts the tumour vessels, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (manipulation of the Tie-2 system in tumours having disrupted the tumour vessels, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (manipulation of the Tie-2 system in tumours that can disrupt the tumour vessels, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (manipulation of the Tie-2 system in tumours which have disrupted the tumour vessels, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (the Lys147Ala substitution being able to disrupt the interaction, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (the Lys147Ala substitution disrupts the interaction, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (the Lys147Ala substitution having disrupted the interaction, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (the Lys147Ala substitution that can disrupt the interaction, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (the Lys147Ala substitution which have disrupted the interaction, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>The 415G4 mutation can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt splicing enhancer sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>The 415G4 mutation can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt splicing enhancer sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>The 415G4 mutation that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt splicing enhancer sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">splicing enhancer sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>These mutations can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt the ubiquitin-binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>These mutations can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt the ubiquitin-binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>These mutations that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt the ubiquitin-binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>This deletion can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt the consensus 5 splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>This deletion can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt the consensus 5 splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>This deletion that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt the consensus 5 splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the consensus 5 splice signal</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>inhibition of inflammation can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt protective physiologic responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>inhibition of inflammation can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt protective physiologic responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>inhibition of inflammation that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt protective physiologic responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiologic responses</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>manipulation of the Tie-2 system in tumours can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt the tumour vessels.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>manipulation of the Tie-2 system in tumours can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt the tumour vessels.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>manipulation of the Tie-2 system in tumours that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt the tumour vessels.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumours</arg>
                    <arg n="1">the tumour vessels</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>the Lys147Ala substitution can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>the Lys147Ala substitution can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>the Lys147Ala substitution that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="SEED" no="1">
                    <text>Arg99 and Arg253 can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA and disrupt the pairing hydrogen bonds in the model.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="SEED" no="2">
                    <text>Arg99 and Arg253 can interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA to disrupt the pairing hydrogen bonds in the model.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="SEED" no="3">
                    <text>Arg99 and Arg253 that interact with the keto groups of the GO and C base pair(blue) in both sides of dsDNA can disrupt the pairing hydrogen bonds in the model.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">the pairing hydrogen bonds in the model</arg>
                </example>
                <example src="SEED" no="4">
                    <text>Importantly, the findings show that the knockout of MEKK1 or MEKK2 expression could not disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="SEED" no="5">
                    <text>Importantly, the findings show that the knockout of MEKK1 or MEKK2 expression did not disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="SEED" no="6">
                    <text>Importantly, the findings show that the knockout of MEKK1 or MEKK2 expression does not disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="SEED" no="7">
                    <text>Importantly, the findings show that the knockout of MEKK1 or MEKK2 expression has not disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="SEED" no="8">
                    <text>Importantly, the findings show that the knockout of MEKK1 or MEKK2 expression is not able to disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="SEED" no="9">
                    <text>Importantly, the findings show that the knockout of MEKK1 or MEKK2 expression will not disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="SEED" no="10">
                    <text>Quantitative single-unit electrophysiology revealed that alcohol exposure disrupted ocular dominance plasticity while preserving robust visual responses.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="SEED" no="11">
                    <text>Quantitative single-unit electrophysiology revealed that alcohol exposure disrupts ocular dominance plasticity while preserving robust visual responses.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="SEED" no="12">
                    <text>Quantitative single-unit electrophysiology revealed that alcohol exposure has been shown to disrupt ocular dominance plasticity while preserving robust visual responses.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="SEED" no="13">
                    <text>Quantitative single-unit electrophysiology revealed that alcohol exposure has disrupted ocular dominance plasticity while preserving robust visual responses.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="SEED" no="14">
                    <text>Quantitative single-unit electrophysiology revealed that alcohol exposure is able to disrupt ocular dominance plasticity while preserving robust visual responses.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="SEED" no="15">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion disrupted the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="SEED" no="16">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion disrupts the open reading frame.&#x09;</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="SEED" no="17">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion has been shown to disrupt the open reading frame.&#x09;</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="SEED" no="18">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion has disrupted the open reading frame.&#x09;</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="SEED" no="19">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion is able to disrupt the open reading frame.&#x09;</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="SEED" no="20">
                    <text>Sequencing of cloned polymerase chain reaction amplified fragments of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion may have disrupted the open reading frame.&#x09;</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="SEED" no="21">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (the Gly188----Glu mutation being able to disrupt an Ava II site, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="SEED" no="22">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (the Gly188----Glu mutation disrupts an Ava II site, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="SEED" no="23">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (the Gly188----Glu mutation having disrupted an Ava II site, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="SEED" no="24">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (the Gly188----Glu mutation that can disrupt an Ava II site, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="SEED" no="25">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (the Gly188----Glu mutation which have disrupted an Ava II site, the Arg243----His mutation, a Hha I site, and the Asp250----Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations.</text>
                    <arg n="0">the Gly188----Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="SEED" no="26">
                    <text>When both genes are disrupted, galS expression is further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression is further elevated</arg>
                </example>
                <example src="SEED" no="27">
                    <text>When both genes are shown to be disrupted, galS expression is further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression is further elevated</arg>
                </example>
                <example src="SEED" no="28">
                    <text>When both genes has already been disrupted, galS expression was further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression was further elevated</arg>
                </example>
                <example src="SEED" no="29">
                    <text>When both genes has been disrupted, galS expression was further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression was further elevated</arg>
                </example>
                <example src="SEED" no="30">
                    <text>When both genes has been observed to be disrupted, galS expression was further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression was further elevated</arg>
                </example>
                <example src="SEED" no="31">
                    <text>When both genes were disrupted, galS expression was further elevated.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">galS expression was further elevated</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
